Stefanie Lerch

Decompressive craniectomy plus best medical treatment versus best medical treatment alone for spontaneous severe deep supratentorial intracerebral haemorrhage: a randomised controlled clinical trial

Jürgen Beck, Christian Fung, Daniel Strbian et al. · The Lancet · 2024 · 94 citations · Full text

Decompressive Craniectomy, Medical Treatment, Interventional Neuroradiology +10

Continuous Sunitinib Treatment in Patients with Advanced Hepatocellular Carcinoma: A Swiss Group for Clinical Cancer Research (SAKK) and Swiss Association for the Study of the Liver (SASL) Multicenter Phase II Trial (SAKK 77/06)

Dieter Koeberle, Michael Montemurro, Panagiotis Samaras et al. · The Oncologist · 2010 · 92 citations · Full text

Multicenter phase II trial of gefitinib first-line therapy followed by chemotherapy in advanced non-small-cell lung cancer (NSCLC): SAKK protocol 19/03

G. D’Addario, Daniel Rauch, Roger Stupp et al. · Annals of Oncology · 2007 · 41 citations · Full text

Medicine, Metronomic Therapy, Gefitinib First-line Therapy +6

SWIFT DIRECT: Solitaire™ With the Intention For Thrombectomy Plus Intravenous t-PA Versus DIRECT Solitaire™ Stent-retriever Thrombectomy in Acute Anterior Circulation Stroke: Methodology of a randomized, controlled, multicentre study

Urs Fischer, Johannes Kaesmacher, Patricia S Plattner et al. · International Journal of Stroke · 2021 · 41 citations

Combination of bevacizumab and 2-weekly pegylated liposomal doxorubicin as first-line therapy for locally recurrent or metastatic breast cancer. A multicenter, single-arm phase II trial (SAKK 24/06)

Christoph Rochlitz, Thomas Ruhstaller, Stefanie Lerch et al. · Annals of Oncology · 2010 · 26 citations · Full text

Metastatic Breast Cancer, Breast Oncology, Medicine +8